4-异丙基苯胺 | 21244-34-8

• 物质功能分类: 有机原料 - 氨基化合物 - 环烷胺、芳香单胺、芳香多胺及其衍生物和盐
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-异丙基苯胺
• 中文别名: 对异丙氧基卞胺
• 英文名称: (4-isopropoxyphenyl)methanamine
• 英文别名: 4-isopropoxybenzylamine；[4-(propan-2-yloxy)phenyl]methanamine；1-(4-Isopropoxyphenyl)methanamine；(4-propan-2-yloxyphenyl)methanamine
• CAS: 21244-34-8
• 化学式: C₁₀H₁₅NO
• mdl: MFCD04037892
• 分子量: 165.235
• InChiKey: BHCAOBYOKNTDLI-UHFFFAOYSA-N

物化性质

• 沸点：
  74℃/0.3mm

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2922299090
• 包装等级：
  III
• 危险类别：
  8
• 危险性防范说明：
  P261,P264,P270,P271,P280,P302+P352,P304+P340,P305+P351+P338,P310,P330,P332+P313,P337+P313,P362,P403+P233,P405,P501
• 危险品运输编号：
  2735
• 危险性描述：
  H302,H315,H318,H332,H335
• 储存条件：
  存储条件：室温、密闭保存，并置于干燥处。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 1-(4-Isopropoxyphenyl)methanamine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 1-(4-Isopropoxyphenyl)methanamine
CAS number: 21244-34-8

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H15NO
Molecular weight: 165.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-异丙基苯胺 在 [ruthenium(II)(η⁶-1-methyl-4-isopropyl-benzene)(chloride)(μ-chloride)]₂ 、 palladium diacetate 、 三甲基乙酸钾 、 potassium carbonate 、 R-(+)-1,1'-联萘-2,2'-双二苯膦 作用下， 以 甲苯 为溶剂， 反应 40.0h， 生成 N-[(4-isopropoxyphenyl)(phenyl)methyl]-3-methylpyridin-2-amine
  参考文献：
  名称：

  芳基溴和芳基氯用于钌(II)介导的苯甲基胺的直接芳基化

  摘要：

  报道了钌(II)催化的苄胺与芳基卤的 sp3 C-H 键芳基化反应。在本方法中，芳基碘化物以及更重要的是更便宜的芳基溴化物和芳基氯化物可以用作芳基源。此外，该方法不需要在手套箱中进行复杂的操作，并且可以在简单的螺旋盖小瓶中进行。新戊酸钾被证明有利于芳基溴或碘化物作为芳基源的转化，但对于芳基氯则不需要。在后一种情况下，PPh3 的添加导致了高转化率。3-甲基和3-苯基吡啶被确定为定向基团，3-位的取代基代表了高转化率的关键结构特征。引导基团可以在转化后裂解，从而获得二芳基甲基胺。进行了机理研究，并与相关转化的机理报告进行了严格的比较。

  DOI：

  10.1002/ejoc.201300004
• 作为产物：
  描述：

  4-异丙氧基苯甲醛 在 乙酸铵 、 盐酸 、 氢氧化钾 、 sodium chloride 、 sodium cyanoborohydride 作用下， 以 甲醇 、 水 为溶剂， 生成 4-异丙基苯胺
  参考文献：
  名称：

  Saturated heterocyclic carboxamide derivatives

  摘要：

  以下是通用公式（I）的饱和杂环羧酰胺衍生物及其盐，具有血小板活化因子（PAF）拮抗活性。

  公开号：

  US04987132A1

文献信息

• [EN] COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES<br/>[FR] COMPOSÉS, SELS CORRESPONDANTS ET MÉTHODES POUR LE TRAITEMENT DE MALADIES
  申请人：ACADIA PHARM INC

  公开号：WO2019040107A1

  公开（公告）日：2019-02-28

  The present disclosure relates to compounds according to Formula (I), useful for treating diseases.

  本公开涉及按照式（I）的化合物，用于治疗疾病。
• Development of Pyridazinone Chemotypes Targeting the PDEδ Prenyl Binding Site
  作者：Sandip Murarka、Pablo Martín-Gago、Carsten Schultz-Fademrecht、Alaa Al Saabi、Matthias Baumann、Eyad K. Fansa、Shehab Ismail、Peter Nussbaumer、Alfred Wittinghofer、Herbert Waldmann

  DOI：10.1002/chem.201603222

  日期：2017.5.2

  The K‐Ras GTPase is a major target in anticancer drug discovery. However, direct interference with signaling by K‐Ras has not led to clinically useful drugs yet. Correct localization and signaling by farnesylated K‐Ras is regulated by the prenyl binding protein PDEδ. Interfering with binding of PDEδ to K‐Ras by means of small molecules provides a novel opportunity to suppress oncogenic signaling. Here

  K‐Ras GTPase是抗癌药物发现的主要目标。但是，对K‐Ras信号转导的直接干扰尚未导致临床上有用的药物。异戊二烯结合蛋白PDEδ调节法尼基化的K-Ras的正确定位和信号传导。通过小分子干扰PDEδ与K-Ras的结合提供了抑制致癌信号的新机会。在这里，我们介绍了基于吡咯并吡啶并酮和吡唑并并吡并并酮以低纳摩尔亲和力与PDEδ的法呢基结合袋结合的新型K-Ras-PDEδ抑制剂化学型的鉴定和结构导向的发展。我们描述了基于吡唑并吡啶并嗪酮的K-Ras-PDEδ抑制剂的结构-性质关系以及体内药代动力学（PK）和毒物动力学（Tox）研究。
• N -[4-(Methylsulfonylamino)benzyl]thiourea analogues as vanilloid receptor antagonists: analysis of structure–activity relationships for the ‘C-Region’
  作者：Jeewoo Lee、Sang-Uk Kang、Ju-Ok Lim、Hyun-Kyung Choi、Mi-kyung Jin、Attila Toth、Larry V Pearce、Richard Tran、Yun Wang、Tamas Szabo、Peter M Blumberg

  DOI：10.1016/j.bmc.2003.10.047

  日期：2004.1

  hylsulfonylamino)benzyl] thiourea (2) was a high affinity antagonist of the vanilloid receptor with a binding affinity of K(i)=63 nM and an antagonism of K(i)=53.9 nM in rat VR1 heterologously expressed in Chinese hamster ovary (CHO) cells (Mol. Pharmacol. 2002, 62, 947-956). In an effort to further improve binding affinity and antagonistic potency, we have modified the C-region of the lead 4-t-butylbenzyl

  我们最近报道，N-（4-叔丁基苄基）-N'-[4-（甲基磺酰基氨基）苄基]硫脲（2）是香草素受体的高亲和力拮抗剂，结合亲和力为K（i）= 63 nM和在中国仓鼠卵巢（CHO）细胞中异源表达的大鼠VR1中K（i）= 53.9 nM的拮抗作用（Mol。Pharmacol。2002，62，947-956）。为了进一步提高结合亲和力和拮抗力，我们用多种替代物（例如芳烷基，烷基，4-炔基苄基，茚满基，3,3-二芳基丙基）修饰了4-叔丁基苄基铅的C区。 4-烷氧基苄基，4-取代的哌嗪和哌啶。亲脂性替代物，芳基烷基和烷基，在结合亲和力和拮抗力上适度降低；具有杂原子的基团导致急剧减少。
• Discovery of 3,6-disubstutited-imidazo[1,2-a]pyridine derivatives as a new class of CLK1 inhibitors
  作者：Yun Zhang、Anjie Xia、Shiyu Zhang、Guifeng Lin、Jingming Liu、Pei Chen、Bo Mu、Yan Jiao、Wenwen Xu、Mingxin Chen、Linli Li

  DOI：10.1016/j.bmcl.2021.127881

  日期：2021.6

  autophagy and it has been thought as a potential target for treatment of autophagy-related diseases. Herein we report the discovery of a series of 3,6-disubstutited-imidazo[1,2-a]pyridine derivatives as a new class of CLK1 inhibitors. Among them, compound 9e is the most potent one, which exhibits an IC50 value of 4 nM against CLK1 kinase. In vitro, this compound reduces the phosphorylation level of

  抑制 cdc2 样激酶 1 (CLK1) 可以有效地诱导自噬，它被认为是治疗自噬相关疾病的潜在靶点。在此我们报告发现了一系列 3,6-二取代的咪唑并[1,2- a ]吡啶衍生物作为一类新的 CLK1 抑制剂。其中，化合物9e是最有效的一种，其对 CLK1 激酶的 IC 50值为 4 nM。在体外，该化合物降低了 CLK1 典型下游底物的磷酸化水平并影响它们的亚细胞重新分布。进一步研究表明，9e可有效诱导自噬。总的来说，这项研究为靶向 CLK1 激酶的药物发现提供了一种有前景的先导化合物。
• Sulphonamido-substituted bridged bicycloalkyl derivatives
  申请人：——

  公开号：US20040029862A1

  公开（公告）日：2004-02-12

  A class of compounds is disclosed, comprising sulphonamido-substituted bridged bicycloalkyl structures. The compounds are inhibitors of gamma-secretase, and hence are useful in the treatment of and/or prevention of Alzheimer's disease.

  揭示了一类化合物，包括磺胺基取代的桥联双环烷基结构。这些化合物是γ-分泌酶的抑制剂，因此在治疗和/或预防阿尔茨海默病方面是有用的。